middle.news
Philippines Partner Backs Firebrick’s Nasodine Expansion With New Stake
8:32am on Monday 12th of October, 2026 AEDT
•
Healthcare
Read Story
Philippines Partner Backs Firebrick’s Nasodine Expansion With New Stake
8:32am on Monday 12th of October, 2026 AEDT
Key Points
$732,000 placement at 3.5 cents a share
Philippines licensing partner lifts holding above 10%
Issue price set at premiums to recent trading levels
Funds directed to US production and Singapore launch
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE